In treating ailments and pursuing rehabilitation, muscle atrophy is the most limiting factor effecting treatment efficiency 22, 34 . The loss of muscle mass due to aging, inactivity, injury and disease increases the likelihood for falls, loss of independence, and decrease in quality of life 8, 9, 20, 22, 23, 32, [34] [35] [36] 39, 40, 44 . Health care costs due to muscle atrophy run up to 18.5 billion (US) per year 9 . Due to the detrimental effect muscle atrophy has on both individuals and the economy; significant advances have been taken in understanding muscle atrophy and the various molecular and signaling pathways activated within the process 8, 9, [23] [24] [25] 34, 35 . In our previous work with the muscle atrophy process we showed that 
Chapter One
Introduction
In treating ailments and pursuing rehabilitation, muscle atrophy is the most limiting factor effecting treatment efficiency 22, 34 . For example, sarcopenia, muscle atrophy due to aging, is prevalent in 10-20% of the population under the age of seventy.
Likewise 40% of the population over eighty years of age experience significant muscle loss 9 . This rapid loss of muscle mass seen in aging as well as following injury, inactivity, and disease increases the likelihood of falls, loss of independence, and decrease in quality of life 8, 9, 20, 22, 23, 32, [34] [35] [36] 39, 40, 44 . Health care costs due to muscle atrophy run up to 18.5 billion (US) per year 9 . Hence, significant advances have been taken in understanding muscle atrophy using pharmacological and genetic manipulation in cells and rodents in order to understand, dampen and inhibit the molecular and signaling pathways that yield skeletal muscle atrophy 8, 9, [23] [24] [25] 34, 35 .
Thus far research has shown that these atrophy inducing conditions each trigger different types of molecular and signaling pathways, however they all share the same outcome in muscle wasting 8, 20, 22, 23, 34, 35, 44 . For example, immobilization can be caused by numerous muscle atrophying conditions such as disease and injury or it can induce muscle atrophy in and of its self. The process causes morphological, physiological and biochemical alterations within skeletal muscle fibers that result in an imbalance of protein synthesis and breakdown. More specifically, immobilization activates the ubiquitinproteasome pathway triggering major contractile protein degradation, noted by the decrease in cross sectional area, myofibers and force production. Immobilization has also shown to reduce myocyte number and decrease satellite cell activity, suggesting activation of apoptosis 8, 17, 20, 39, 44 . Other research supports that the decrease in muscle mass is attributed to cellular events involving protein degradation, in addition to mitochondrial dysfunction and loss of myonuclei 8, 17, 25, 30, 35, 39, 44 . Currently, there are many different pathways which regulate muscle atrophy, however two of the more prominent pathways include protein ubiquination and apoptosis 8, 10, 17, [22] [23] [24] [25] 29, 34, 35, 39 .
Regulation of skeletal muscle mass is controlled primarily through the AKT/mTOR pathway 23 . The AKT/mTOR pathway typically promotes muscle growth, however when stimuli such as inactivity, disease, injury and aging disregulates the pathway through AKT depsosphorylation, it prevents AKT from phosphorylating the prodegradtory forkhead transcription factor FoxO1 3, 20, [23] [24] [25] [31] [32] [33] [34] . FoxO1 which consists of four domains: a forkhead DNA-binding domain, a nuclear localization signal, a nuclear export sequence, and a C-terminal transactivation domain 3, 12, 27 is regulated by AKT.
AKT creates sites for 14-3-3 binding on FoxO1 proteins which in turn promotes further phosphorylation by casein kinase-1 and tyrosine kinase-1A 3, 4, 12, 27, 32 . Collectively the formation of this complex inhibits FoxO1's function and keeps it sequestered in the cytosol 3, 4, 12, 23, 27, 32, 37 . However when FoxO1 is dephosphorylated it becomes active and translocates to the nucleus where it promotes upregulation of various transcription factors 23 . Studies have shown that in a variety of tissues FoxO1 has been found to regulate atrophy through both proteolytic and apoptotic pathways 1, 12, 15, 20, 21, 24, 27, 37 .
FoxO1 most notoriously regulates protein ubiquination by upregulating the expression of genes Muscle Atrophy F-box (Atrogin-1/MAFbx) and Muscle Ring Finger1 (Murf-1) 22, 29, 34, 35 . These genes when overexpressed, promote the formation of the ubiquitin complex composed of ubiquitin and E3 ligases 29, 35, 39 . The ubiquitin complex in turn selectively targets specific proteins for degradation. Once the proteins of interest are tagged with ubiquitin they are rapidly degraded by the 26S proteasome 22, 29, 35, 39 .
Another form of atrophy seen within skeletal muscle is caused by apoptosis or programmed cell death. This intracellular death pathway kills cells in a controlled fashion through compartmentalization of cellular components which are then phyagocytosed 28, 29 .
The process is characterized by DNA fragmentation, loss of nuclei, and mitochondrial disruption and remodeling 7, 29, 41, 42 . Furthermore, it can be regulated through two different routes which include the mitochondria (intrinsic route) and the activation of death receptors (extrinsic pathway) 13, 38, 42 . Several studies on muscle atrophy have found that mitochondrial disruption is a prominent characteristic seen in the muscle wasting process;
therefore, it appears that the primary route of apoptosis within skeletal muscle is intrinsic 6, [8] [9] [10] 39 . The intrinsic apoptotic pathway is controlled primarily by the ratio of pro and anti-apoptotic proteins within the mitochondria 6, 38, 42 . Pro-apoptotic genes Bim and BNip3 act on anti-apoptotic Bcl-2, inhibiting its function 5, 6, 14, 15, 19, 28, 43 . Once Bcl-2 is inhibited, cytochrome c is released into the cytoplasm and binds with Apaf-1 and Procaspase 9 to form an apoptosome 7, 10, 13, 38, 42 . The formation of this complex in turn activates caspase-9 which will in turn activate the rest of the effector caspases 7, 10, 11, 13, 38, 42 . 
Chapter Two
Literature Review
Mechanisms of Skeletal Muscle Atrophy
The primary functions of skeletal muscle are to provide power and strength for locomotion and posture in addition to acting as a store for body proteins and thermoregulation. In order for skeletal muscle to function at optimal efficiency it is imperative that skeletal muscle proteins maintain homeostasis between synthesis and degradation. When the homeostatic balance is off amongst the proteins, protein degradation occurs. This loss of skeletal muscle mass yields deterioration in the performance of activities of daily living in addition to dampened metabolic function due to the change in physiological demands caused by the muscle loss 9, 35, 39, 40 . Muscle atrophy can be triggered by several mechanisms, some of which include: neuromuscular disease, chronic disease, immobilization, injury and aging 8, 9, 20, 22, 23, 32, [34] [35] [36] 40, 44 . In the paragraph to follow I will divulge some of the details as to how these various mechanisms trigger muscle atrophy.
At a glance, the mechanisms that trigger muscle atrophy appear to be diverse and have little in common; however the exact opposite is true. Many of the mechanisms in one form or other trigger similar molecular pathways in order to induce skeletal muscle atrophy 6, 8, 9, 12, 14, 20, 22, 30, 35, 36, 39 . For example, in neuromuscular diseases, chronic diseases and aging there is significant accumulation of mitochondrial DNA mutations 8, 9, 15, 22, 30 .
The accumulation of mitochondrial DNA mutations compromises the integrity of the cell triggering the apoptotic pathway 8, 9, 14, 22, 30 . Furthermore, in heart disease, various injuries and in aging again; ATP production can be inhibited under hypoxic conditions which triggers both proteolytic and apoptotic degradation 6, 8, 9, 17, 20, 30, 35, 39 . Collectively as you can see, any compromise in mitochondrial integrity, oxygen or ATP supply will trigger protein degradation and apoptosis within skeletal muscle cells. Due to these observations much research has been done in understanding the specifics of these catabolic pathways and many have found that AKT is a pivotal point in atrophy signaling pathways 3, 4, 15, 20, 23, 24, 27, [31] [32] [33] 37 . On a phenotypic level the activation of these pathways results in decreased muscle cross sectional area, mitochondrial dysfunction, loss of myonuclei and of course protein degradation 8, 17, 25, 30, 35, 39, 44 . Since health care costs due to muscle atrophy run up to 18.5 billion (US) per year, it is imperative that advances in understanding atrophy using pharmacological and genetic manipulation in cells and rodents continues to take place in order to find a treatment or cure for muscle atrophy 8,9,23-25,34,35 .
Protein Ubiquination
Within skeletal muscle half of muscle protein is made of up myofibril protein, this fraction of protein is lost at a faster rate than other muscle proteins in skeletal muscle atrophy 9, 20, 22, 39 . A majority of the proteolysis in muscle appears to be due to the activation of the ubiquitin-proteasome pathway 20, 22, 35, 39 . The ubiquitin-proteasome pathway is a major extralysosomal pathway that is responsible for promoting the intracellular degradation of proteins 22, 29 . In fact, several models of muscle atrophy; including:
starvation, uremia, denervation, sepsis, and diabetes mellitus have activated the ubiquitinproteasome pathway 20, 35 .
Although there is substantial variability in the physiological and pathophysiological stimuli for muscle atrophy, it appears that there are striking similarities in transcriptional adaptations of genes coding for the ubiquitin-proteasome pathway 22 . The ubiquitin-proteasome pathway is composed of a ubiquitin conjugating system and 26S proteasome 29 . This system is comprised of several classes of enzymes;
ubiquitin activating enzymes (E1) which modify ubiquitin so that it is in a reactive site, ubiquitin conjugating enzyme (E2) which catalyzes the attachment of the ubiquitin protein, and ubiquitin ligases (E3) which functions to recognize the substrate protein and aid E2 enzymes in the attachment to the substrate protein 20, 29 . Together this complex tags specific proteins for degradation by the 26S proteasome 29, 35 .
In 2001, following a screening for genes upregulated in different models of rodent muscle atrophy, genes Atrogin-1/MAFbx and Murf-1 were discovered 2, 16 . Since their discovery, several studies including those looking at cardiomyopathies have found that
Atrogin-1/MAFbx and Murf-1 are the key E3 ligases utilized in muscle atrophy thorough protein ubiquination 24, 34, 35 . In fact, in Murf-1 knockout mice subjected to muscle denerveation, there was a 36% decrease in the amount of muscle atrophy at 14 days.
Likewise in Atrogin-1/MAFbx knockout mice 56% of muscle was spared from 
Apoptosis
Apoptosis or programmed cell death is a distinct intrinsic cell death program that occurs in various physiological and pathological situations 7, 10, 14, 18, 28, 29, 42 . It is characterized by typical morphological and biochemical hallmarks including cell shrinkage, nuclear DNA fragmentation, membrane blebbing, and mitochondrial disruption and remodeling 7, 29, 42 . This degrative pathway allows for the death and removal of a single cell without disturbing the surrounding tissue 9, 13 and is therefore, essential for the development and maintenance of tissue homeostasis in highly proliferative cells such as those found in the intestine, liver, white blood cells and stem cells. Although apoptosis is seen extensively in highly proliferative cells, it is still somewhat controversial as to whether or not apoptosis occurs in postmitotic tissue such as the brain, heart and skeletal muscle 1, 6, [8] [9] [10] 17, 18, 37 .
Apoptosis as a whole occurs through the activation of cysteine proteases Many of the key components that initiate and execute apoptosis have been found to be conserved across species 41 . However, detection of apoptosis in vivo is difficult because it is asynchronous and the half life of apoptotic cells in tissue is short 42 . Thus far, through extensive research apoptosis has been found to occur within the cardiovascular system, the neurological system and skeletal muscles as a result of a number of stimuli including: hypoxia, denervation, immobilization and aging 1, 6, [8] [9] [10] 14, 17, 30, 37, 39 .
Apoptosis plays an important role within the cardiovascular system not only in the process of homeostasis and development but also in the pathogenesis of certain diseases 6, 18, 37 . It is implicated in the death of myocytes in animal models of myocardial ischemia, and in humans with acute myocardial infarction and congestive heart failure 18 .
Cell death induced by ischemic stress of cardiomyocytes occurs through the mitochondrial pathway which is partially regulated by Bcl-2 family proteins 6,18,37 .
Pro-apoptotic protein BNip3 (Bcl-2 and nineteen-kilodalton interacting protein-3)
is strongly activated by hypoxia such as that seen with cardiac damage 6 . In fact through subtractive hybridization studies, BNip3 has been found to be the most prominent hypoxia responsive gene 5, 6 . BNip3 functions through binding to and inhibiting antiapoptotic Bcl-2 which allows cytochrome-c to be released from the mitochondria leading to degradation 5 . In addition to cardio myocytes BNip3 has also been found to induce Therefore, it appears that BNip3 can interact with both apoptotic and autophagic transcription factors 5 . Furthermore, in studies utilizing neonatal rat cardiac myocytes exposed to hypoxia and acidotic conditions BNip3 caused cell death resembling apoptosis that was independent of caspase activation suggesting that BNip3 induces both apoptotic and non-apoptotic cell death depending on the stimulation and/or cell type 5, 6 . Apoptosis has been documented to occur in muscle dystrophy, chronic heart failure, skeletal muscle denervation, muscle unweighting and during acute exercise [8] [9] [10] 17, 18, 30, 37, 39, 44 . However, relatively few studies have been published looking at the role of apoptosis in loss of muscle mass and function in aging muscle 8, 9 . In most cell types removal of the nuclei equates into apoptosis of the entire cell, unlike other cells in the body, skeletal muscle is multinucleated so apoptosis of a nucleus may not cause apoptosis of the entire cell [8] [9] [10] 39 . The process by which nuclei are removed from muscle fibers resembles apoptosis, however since destruction of the entire cell does not occur, the process within skeletal muscle is termed "apoptotic nuclear death" 10, 17 .
It has been postulated that the loss of cells in post-mitotic tissue such as skeletal muscle via apoptosis activation contributes to the age-related decline in function 8, 9, 30, 44 .
Current research has noted that aged skeletal muscle is characterized by increased mitochondrial dysfunction which correlates with the fact that mitochondrial dysfunction is a potent mechanism of apoptotic induction via the internal pathway 8, 9, 30, 44 . Within the mitochondria several key death factors reside between the inner and outer membrane 11 . In addition to Bim and BNip3, caspase independent AIF (apoptosis inducing factor) and endonuclease G (endo-G) are located within the mitochondria and upon disruption, can cause large scale DNA fragmentation and apoptosis by translocating to the nucleus 11, 41 .
One study has found that endo-G co-localization with the nuclei increased in muscles atrophied by hind limb suspension and age and concentrations further increased with aged rats undergoing disuse induced atrophy 9 . Furthermore, it has also been found that endo-G translocation is very specific for myonuclei and not involved in apoptosis of interstitial cells 9 . Even with evidence of endonuclease G translocating to the myonuclei in apoptosis there is still much to be discovered behind the mechanisms involved in myonuculear loss in atrophy 10, 17 . AIF is a flavin-adenine dinucleatide (FAD)-binding oxidoreductase, however neither its FAD-binding activity nor its oxidoreductase activity is required for its apoptogenic activity 41 . Therefore, it has been suggested that AIF's action is that which is utilized to remove unnecessary or unused muscle tissue in an effort to conserve the proteins for other bodily needs in aging and that AIF is the unknown mechanism responsible for myonuclei removal 11,41 .
FoxO1
Transcription factors are modular proteins with distinct functions contained within defined domains, such as DNA-binding and transactivation of transcription 3 Furthermore, the Fox name was given to the protein after its' founding gene member was discovered in Drosophila 3, 4, 27, 31 . Genes encoding forkheads are present throughout the animal kingdom as well as in yeast and fungi 31 . In humans specifically, over 100 genes encoding forkhead proteins are present in the genome; therefore, due to the vast number, the forkhead proteins are classified into subgroups based on sequence similarity 31 .
The O subfamily of forkhead (Fox) proteins regulates hormonal, nutrient, and stress responses to promote cell survival and metabolism 3, 4, 12, 20, 27, 31, 32 . Of the numerous subgroups they are the most divergent of the Fox family due to a unique five amino-acid insertion found prior to the helix H3 within the forkhead domain. This domain has been found to be directly involved in sequence specific interaction with DNA-binding sites. 
Chapter Three Materials and Methods

Retroviral Transfections
FoxO1-estrogen receptor (FoxO1-ER) fusion proteins that are activated by treatment of 4 OH-T were stably expressed in C2C12 skeletal myoblasts using a pBABE retroviral system. Briefly, cells were seeded in flat-bottom culture plates and grown iin DMEM supplemented with 10% FBS (culture medium). At ~50% confluence, cells were placed in culture medium supplemented with polybrene (10 µg/ml) and transfected overnight with one of four retroviral constructs. Positively transfected cells were selected by incubating myoblasts in culture medium supplemented with puromycin (Specialty Media, Temecula, CA; 3.5 µg/ml) for 24 hours. The two retroviral constructs included for up to 48 hours.
Protein Quantification
For protein quantification, C2C12 myotubes were collected in a buffer containing 10 mM MgCl 2 , 10 mM KH 2 PO 4 , 1 mM EDTA, 5 mM EGTA, 50 mM • -glycerolphosphate, 10 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM leupeptin, 10 mM aprotinin, and 10 mM Na 3 VO 4 . Total protein concentration was assayed with a detergent-compatible protein assay kit (DC Protein Assay, Bio-Rad, Hercules, CA) and quantified by spectrophotometry using a microtiter plate reader (SpectraMax 190; Molecular Devices, Sunnyvale, CA).
Gene Expression Analysis
Total RNA was isolated using an Rneasy Mini column (Qiagen, Valencia, CA), 
Statistical Analyses
A two-way factorial ANOVA (p • 0.05) was used to determine differences between conditions for all dependent variables assessed. Neuman-Keuls post-hoc analyses (p • 0.05) were used to locate differences between means if a significant main effect and/or interaction was found. (Fig. 4.1 ).
Chapter Four Results
Impaired
Murf-1 gene expression was elevated in a similar manner following 4 OH-T treatment for the FoxO1 AAA-ER (~2 fold) and FoxO1 AAA/Arg215-ER cells (~2.2 fold), which were both greater than gene expression measured in the non-trasfected condition ( Fig. 4 .2), indicating that FoxO1 can regulated the expression of Murf-1 through a mechanism that is independent of DNA binding.
Gene expression of Bim was significantly elevated in both the FoxO1 AAA-ER (~3.5
fold) and the FoxO1 AAA/Arg215-ER (~2 fold) cells, both of which were greater than the nontransfected condition (Fig. 4.3) . 
Chapter Five Discussion
The prominent findings from this study reveal that muscle atrophy consequential of FoxO1 protein activation culminates from various mechanisms, including increased activity of protein ubiquination and apoptotic machinery. While the ability of FoxO1 to induce muscle atrophy does not appear to be dependent on DNA binding; its effects on protein ubiquination and apoptosis appear to be caused by a direct interaction of FoxO1 and promoter binding sites.
Great evidence concerning FoxO1 expression to skeletal muscle atrophy through the upregulation of genes associated with muscle protein degradation, such as Atrogin- Together with these changes in proteasome-related genes, we saw distinct findings in terms of protein ubiquination subsequent activation of FoxO1 in the various cell lines. Particularly, total protein ubiquination appeared to be elevated in the It is possible that abrogated FoxO1-DNA binding caused a delay rather than a complete loss in apoptotic signal transduction. However due to difficulties in maintaining proper muscle cell integrity with prolonged exposure to 4 OH-T we were unable to achieve reliable data beyond 24 hours for histochemical measurements. Therefore, it looks as if the differences in apoptotic signaling witnessed between the FoxO1 AAA-ER and FoxO1 AAA/Arg215-ER cell lines were the result of differences in DNA binding capability. The conclusions drawn from this study supply further insight into the multifaceted role of FoxO1 within the biological regulations of skeletal muscle. In particular, in remodeling of atrophied skeletal muscle generated through FoxO1 activation, may rely upon both DNA binding dependent and independent mechanisms. Although, in vitro work is no where near the complexity of that of an integral physiological system, it is feasible that the increases in FoxO1 expression may be a powerful driving force for breakdown and removal of muscle proteins and nuclei through the activation of apoptotic machinery associated with conditions such as neuromuscular disease, chronic disease, immobilization, injury and aging. In light of FoxO1's intricate ability to regulate cellular function, thorough contemplation should be given in the development of pharmaceutical, gene therapy and rehabilitation approaches in endeavors to hinder FoxO1-induced muscle atrophy.
